Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 31 min ago
Peer-reviewedCC BYInternational Journal of Nanomedicine

Mitochondria-Targeted Delivery of Doxorubicin to Enhance Antitumor Activity with HER-2 Peptide-Mediated Multifunctional pH-Sensitive DQAsomes [Retraction]

  • Shi M1
  • Zhang J
  • Li X
  • Pan S
  • Li J
  • Yang C
  • Hu H2
  • Qiao M
  • Chen D
  • Zhao X
  1. 1shenyang pharmaceutical university
  2. 2School of Pharmacy
Read full textCite

Abstract

Shi M, Zhang J, Li X, Pan S, Li J, Yang C, Hu H, Qiao M, Chen D, Zhao X. Int J Nanomedicine. 2018;13:4209-4226. https://doi.org/10.2147/IJN.S163858 We, the Editors and Publisher of the journal International Journal of Nanomedicine, have retracted the published article After publication, concerns have been raised by a third party in 2025 about the integrity of the data in Figures 1 and 9 of the article. Further investigation conducted by the Journal and Publisher confirmed unexpected similarities between the TUNEL assay images representative of different samples and treatment conditions in Figure 9B, and unusual similarities between the TEM images in Figure 1. When approached for an explanation, the authors have provided their raw data for Figures 1 and 9B. However, further integrity concerns have been identified in the raw data provided. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed. We have been informed in our decision-making by our editorial policies and the COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

Related

  1. Melatonin Mitigates Doxorubicin‐Induced Cardiotoxicity by Targeting the USP18/PKM2 Axis Without Compromising Antitumor Efficacy
    Zhenyu Feng, Yijin Yang, Jie Bai +8
    Advanced SciencePeer-reviewedCC BY 4.0Full textCardiovascular medicinePMC
  2. Statement of Retraction: Fischer's oligopeptide ratio in ischemic hypoxia: prophylactic amendment of sophoretin and melatonin supplementation.
    Future science OAPeer-reviewedCC BYFull textNeurologyEurope PMC
  3. Statement of Retraction: Baicalin regulates macrophages polarization and alleviates myocardial ischaemia/reperfusion injury via inhibiting JAK/STAT pathway.
    Pharmaceutical biologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMCDOAJ
  4. Statement of Retraction: Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
    Cancer biology & therapyPeer-reviewedCC BYFull textOncologyEurope PMC
  5. Long-Noncoding RNA PCAT6 Aggravates Osteosarcoma Tumourigenesis via the MiR-143-3p/ZEB1 Axis [Retraction].
    OncoTargets and therapyPeer-reviewedCC BY-NCFull textOncologyEurope PMC

Cite

BibTeXRIS
BibTeX
@article{shi2026mitochondriatargeted,
  title = {{Mitochondria-Targeted Delivery of Doxorubicin to Enhance Antitumor Activity with HER-2 Peptide-Mediated Multifunctional pH-Sensitive DQAsomes [Retraction]}},
  author = {Shi M and Zhang J and Li X and Pan S and Li J and Yang C and Hu H and Qiao M and Chen D and Zhao X},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  month = nov,
  url = {https://www.dovepress.com/retraction-mitochondria-targeted-delivery-of-doxorubicin-to-enhance-an-peer-reviewed-fulltext-article-IJN},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Mitochondria-Targeted Delivery of Doxorubicin to Enhance Antitumor Activity with HER-2 Peptide-Mediated Multifunctional pH-Sensitive DQAsomes [Retraction]
AU  - Shi M
AU  - Zhang J
AU  - Li X
AU  - Pan S
AU  - Li J
AU  - Yang C
AU  - Hu H
AU  - Qiao M
AU  - Chen D
AU  - Zhao X
PY  - 2026
DA  - 2026/11/08
JO  - International Journal of Nanomedicine
UR  - https://www.dovepress.com/retraction-mitochondria-targeted-delivery-of-doxorubicin-to-enhance-an-peer-reviewed-fulltext-article-IJN
AB  - Shi M, Zhang J, Li X, Pan S, Li J, Yang C, Hu H, Qiao M, Chen D, Zhao X. Int J Nanomedicine. 2018;13:4209-4226. https://doi.org/10.2147/IJN.S163858 We, the Editors and Publisher of the journal International Journal of Nanomedicine, have retracted the published article After publication, concerns have been raised by a third party in 2025 about the integrity of the data in Figures 1 and 9 of the article. Further investigation conducted by the Journal and Publisher confirmed unexpected similarities between the TUNEL assay images representative of different samples and treatment conditions in Figure 9B, and unusual similarities between the TEM images in Figure 1. When approached for an explanation, the authors have provided their raw data for Figures 1 and 9B. However, further integrity concerns have been identified in the raw data provided. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed. We have been informed in our decision-making by our editorial policies and the COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
SN  - 1178-2013
ER  -